RxDoctor Payments Data

Adrian Ieraci, DO

Family Medicine · North Lima, OHNPI 1376522326

Payments from drug & device makers

$296in general payments, 2019–2025

Across 41 payments — averaging $7.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$125
  • Amarin Pharma, Inc.$51
  • Amgen$43
  • Sanofi Pasteur Inc.$29
  • GSK$19
  • Lilly USA, LLC$16
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$296100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$296 in reported general payments places this provider in the 40th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$110,873
Medicare patients
285
Services billed
2,298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban264$273,695
XareltoRivaroxaban116$101,861
OzempicSemaglutide90$94,562
TradjentaLinagliptin75$87,083
JanuviaSitagliptin Phosphate62$77,698
JardianceEmpagliflozin38$56,720
TrulicityDulaglutide48$48,554
MounjaroTirzepatide39$44,811
LinzessLinaclotide50$36,745
EntrestoSacubitril/Valsartan17$24,654
Tresiba Flextouch U-200Insulin Degludec27$23,361
MyrbetriqMirabegron24$19,742
Repatha SyringeEvolocumab32$15,374
Repatha SureclickEvolocumab24$14,649
Breo ElliptaFluticasone/Vilanterol29$14,422

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$273,695264 claims
Novo NordiskOzempic$125$94,56290 claims
Lilly USA, LLCTrulicity, Mounjaro$16$93,36587 claims
GSKBreo Ellipta$19$14,42229 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in North Lima

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →